2022年全年产品销售
下表提供了2022年创新药品部门对第三方的前20大产品净销售额以及与2021年相比的变化:
| Brands |
Net Sales (USD m) |
% change (USD) |
% change (cc2) |
按治疗领域、其他推广品牌或知名品牌分类 |
|---|---|---|---|---|
| Cosentyx | 4,788 | 1 | 5 | Immunology |
| Entresto | 4,644 | 31 | 37 | Cardiovascular |
| Promacta/Revolade | 2,088 | 4 | 9 | Hematology |
| Gilenya | 2,013 | -28 | -24 | Neuroscience |
| Tasigna | 1,923 | -7 | -1 | Hematology |
| Lucentis | 1,874 | -13 | -4 | 其他推广品牌 |
| Tafinlar + Mekinist | 1,770 | 5 | 11 | Solid Tumors |
| Jakavi | 1,561 | -2 | 9 | Hematology |
| Zolgensma | 1,370 | 1 | 5 | Neuroscience |
| Xolair1 | 1,365 | -4 | 6 | Immunology |
| Sandostatin | 1,238 | -12 | -10 | Established Brands |
| Kisqali | 1,231 | 31 | 38 | Solid Tumors |
| Ilaris | 1,133 | 7 | 15 | Immunology |
| Kesimpta | 1,092 | 194 | 200 | Neuroscience |
| Galvus Group | 859 | -21 | -12 | Established Brands |
| Gleevec/Glivec | 745 | -27 | -22 | Established Brands |
| Exforge Group | 743 | -18 | -12 | Established Brands |
| Diovan Group | 652 | -16 | -9 | Established Brands |
| Kymriah | 536 | -9 | -2 | Hematology |
| Afinitor/Votubia | 512 | -45 | -41 | Established Brands |